A pipeline innovated by the global human crisis.
The global human crisis of addiction doesn’t stop at opioid dependency. It expands into other substances and even related mental health conditions. This is why we continue to innovate and evolve.
This is why our pipeline grows with urgency and care. It is designed to meet the growing needs of addictive diseases around the world and to provide treatment to those who need it most.
Our primary focus is patients’ unmet needs, including relapse, diversion and abuse, with a view to developing products that enhance the treatment experience for patients and physicians. Our approach is to leverage existing compounds and technologies to develop potentially transformational treatments for addiction and other CNS disorders. Our R&D team is committed to working in partnership with physicians and the wider medical community to explore new frontiers and discover new science.